BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, ...

AUTX-703, a novel and potent oral KAT2A and KAT2B protein degrader, inhibits growth and induces profound, persistent cell state differentiation in SCLC modelsNEWTON, Mass., April 03, 2025 (GLOBE ...

Chuck Todd says he is launching a media empire—and is preparing to spend up to a whopping $2 billion to do so. Todd told The ...

Vittorio Pirbazari’s friend suggested that he might have suffered a heart attack while working out at the gym.